3Dresyn VAM EA20 Bio, Biocompatible elastic resin with Shore A20 printable by VAM 3D printers

Product description

3Dresyn VAM EA20 Bio is an elastic photopolymer for VAM 3D printers.

This material is designed to be elastic without breaking, providing properties similar to elastic rubber for high resolution VAM printing workflows.

Application framework

Designed for use in VAM 3D printers for fabrication of elastic parts requiring high impact resistance, very high resolution and very low shrinkage.

Typical applications

• Elastic printed parts
• VAM printed parts with properties similar to elastic rubber
• High resolution elastic VAM printing applications

Measured mechanical properties

• Tensile strength: <10 MPa (ISO 527-1 / ISO 527-2)
• Flexural strength: <10 MPa (ISO 178)
• Young’s modulus: <2 MPa (ISO 527)
• Elongation at break: >250% (ISO 527)
• Shore hardness: A20 (ISO 868)

Measured physical properties

• Viscosity: <60.000 mPas at 23°C ± 2°C (ISO 3219)
• Density: 1.0-1.1 g/cc at 25ºC (ISO 1183)
• Refractive index: 1.47-1.49
• Shrinkage: very low

Functional performance characteristics

• Elastic without breaking
• 100% biocompatible
• Ultra safe and toxic pictograms free
• Ultra non yellowing
• High impact and shattering resistance
• Properties similar to elastic rubber
• Durable
• Very high resolution

Processing and handling performance

• High viscous resin with low flow at room temperature
• Printable by VAM 3D printers
• Addition of a suitable photo accelerant and resolution-er system is required for printing in specific VAM printers
  

Chemical and safety characteristics

• 100% biocompatible
• Ultra safe and toxic pictograms free
• Synthetic resin source
• Ultra low organo-tin content
• Ultra non yellowing

Testing & processing disclaimer

Final elasticity, printability and mechanical performance must be validated by the user according to the intended application, printer configuration and processing conditions.

Disclaimer

This material is supplied as a professional manufacturing material and is not marketed as a finished medical device. Final part performance and suitability must be validated by the user according to the intended application.

Document reference: TDS-3DRESYN-VAM-EA20-BIO-EN | Version: 1.0 | Last updated: March 2026